---
figid: PMC11911380__fphar-16-1515864-g002
figtitle: Inflammatory crosstalk and anti-inflammatory mechanisms in the angiotensin
  II-induced fibrosis pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11911380
filename: fphar-16-1515864-g002.jpg
figlink: /pmc/articles/PMC11911380/figure/F2/
number: F2
caption: Inflammatory crosstalk and anti-inflammatory mechanisms in the angiotensin
  II-induced fibrosis pathway. (By Figdraw) AngII mediates the PI3K/AKT signaling
  pathway and participates in upstream PTEN, downstream TGF-ß, m TOR, FoxO3a and e
  NOS signaling pathways, as well as the P38MAPK, JAK/STAT3 and NF-κB signaling pathways,
  and NF-κB further activates the NLRP3 inflammatory vesicles, releasing IL-1ẞ, IL-18.Anti-inflammatory
  drugs act on the corresponding inflammatory pathways. TLR, Toll-like Receptor; IGF
  1, Insulin-like growth factor 1 ;TNF, Tumor necrosis factor; TGF-B, Transforming
  growth factor-ß; IL, Interleukins; PI3K,Phosphatidylinositol 3-kinase;PIP3,Phosphatidylinositol
  Trisphosphate;PDK,Phosphatidylinositol-dependent kinase;FoxO3a, Forkhead box 03;mTOR,
  The Mechanistic Target of Rapamycin;e NOS,Endothelial nitric oxide synthas;JAK,Janus
  tyrosine Kinase;STAT,Signal Transducer and Activator of Transcription; NF-κB, Nuclear
  factor kappa-B protein;NLRP3, NOD-, LRR-, and pyrin domain-containing protein 3
papertitle: Inflammation pathways as therapeutic targets in angiotensin II induced
  atrial fibrillation
reftext: Ailin Hou, et al. Front Pharmacol. 2025;16(NA).
year: '2025'
doi: 10.3389/fphar.2025.1515864
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: atrial fibrillation | inflammation | AngII | electrical remodelling | fibrosis
  | anti-inflammatory therapy
automl_pathway: 0.842524
figid_alias: PMC11911380__F2
figtype: Figure
redirect_from: /figures/PMC11911380__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11911380__fphar-16-1515864-g002.html
  '@type': Dataset
  description: Inflammatory crosstalk and anti-inflammatory mechanisms in the angiotensin
    II-induced fibrosis pathway. (By Figdraw) AngII mediates the PI3K/AKT signaling
    pathway and participates in upstream PTEN, downstream TGF-ß, m TOR, FoxO3a and
    e NOS signaling pathways, as well as the P38MAPK, JAK/STAT3 and NF-κB signaling
    pathways, and NF-κB further activates the NLRP3 inflammatory vesicles, releasing
    IL-1ẞ, IL-18.Anti-inflammatory drugs act on the corresponding inflammatory pathways.
    TLR, Toll-like Receptor; IGF 1, Insulin-like growth factor 1 ;TNF, Tumor necrosis
    factor; TGF-B, Transforming growth factor-ß; IL, Interleukins; PI3K,Phosphatidylinositol
    3-kinase;PIP3,Phosphatidylinositol Trisphosphate;PDK,Phosphatidylinositol-dependent
    kinase;FoxO3a, Forkhead box 03;mTOR, The Mechanistic Target of Rapamycin;e NOS,Endothelial
    nitric oxide synthas;JAK,Janus tyrosine Kinase;STAT,Signal Transducer and Activator
    of Transcription; NF-κB, Nuclear factor kappa-B protein;NLRP3, NOD-, LRR-, and
    pyrin domain-containing protein 3
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TREM1
  - RORC
  - THOP1
  - LINC00273
  - TOP1
  - TOP1MT
  - TOP3A
  - TOP3B
  - TOP2A
  - TOP2B
  - TBPL1
  - IL18
  - RPL18
  - IGKV1D-13
  - IGKV1-13
  - TNF
  - RAC1
  - RNASE1
  - MAK
  - ALPK3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - Phosphate group
  - mega
---
